Table of Contents
Catalysts, Volume 8, Issue 2 (February 2018)
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Cover Story (view full-size image) (S)-Rivastigmine is a blockbuster drug heavily used for the treatment of mild to moderate dementia [...] Read more. (S)-Rivastigmine is a blockbuster drug heavily used for the treatment of mild to moderate dementia of the Alzheimer’s type. An original whole-cell-based and environmentally friendly chemoenzymatic approach has been developed for the obtainment of the target eutomer in four steps, in overall 78% yield and 98% ee. The key step is the stereoselective bioreduction in a phosphate buffered saline medium of an aromatic ketone catalyzed by cheap and easily available Lactobacillus reuteri DSM 20016 whole cells. Interestingly, the described protocol has also been successfully performed on a gram scale, and is amenable for being scaled-up to industrial level. View this paper